ArticleBlood cancer journal2023

Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.

Maymona G Abdelmagid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.